Recently by Blaine Templeman
Biotechnology | Healthcare | Life Sciences
In The Rush To Emerging Markets, Could Public Health Be The Winner?
What is the crashing noise so many pharmaceutical companies are hearing these days? Some say it is the sound of key products going over the “patent cliff.” The press has focused recently on the number of blockbuster drugs that are coming off or have come off patent. The news has...
Read More